Success Stories: NIW Petition Approved for a Primary Care Physician from Lebanon in the Field of Clinical Medicine in 18 Days Only, Thanks to Premium Processing
Client’s Testimonial:
“Honestly, I loved the whole process. Initially, I felt that there were some repetition and that it was a bit slower than expected, but I realised that you guys take time to review to get the best results. Now I can say that you guys are professional and well organised and know very well what you’re doing. I want to thank you, and I hope I get the approval soon to be more happy and satisfied. Thank you.”
On March 1st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Primary Care Physician in the Field of Clinical Medicine (Approval Notice).
General Field: Clinical Medicine
Position at the Time of Case Filing: Primary Care Physician
Country of Origin: Lebanon
State of Residence at the Time of Filing: Florida
Approval Notice Date: March 1st, 2025
Processing Time: 18 days (Premium Processing Requested)
Case Summary:
Based on the huge number of successful cases, North America Immigration Law Group has developed the most up-to-date winning strategies for the NIW category, which enable us to offer our “Approval or Refund” services to many of the NIW cases we take. However, there are certain prerequisites to be fulfilled by an individual, including:
- The foreign national must be in a position to advance the proposed endeavor.
- The applicant must present evidence that the U.S. would benefit on balance to waive the job offer criteria for an EB-2.
- A proposed endeavor, holding substantial merit and national importance.
Our client, a primary care physician from Lebanon, approached us to file an NIW (National Interest Waiver Petition) on his behalf.
He has completed his MBBS, and as an expert in the field of clinical medicine, his proposed endeavor of studying the mechanisms and prevalence of antimicrobial resistance and exploring strategies to limit the spread of antimicrobial resistance and facilitate early detection, management, and treatment of infections has both substantial merit and national importance.
Therefore, to make a persuasive case in his favor, we included the following details in his petition packet:
- His work has resulted in 11 peer-reviewed journal articles (4 of them first-authored) and 2 conference abstracts.
- His publications have been cited a total of 898 times, according to Google Scholar.
Furthermore, he intends to continue his research on studying the mechanisms and prevalence of AMR and exploring strategies to address challenges in future pandemic-related health emergencies to limit the spread of AMR and facilitate early detection, management, and treatment of infections. Specifically, he will screen, vaccinate, and treat infections, monitor antimicrobial susceptibilities, study mechanisms of AMR, conduct early screening and detection of various medical conditions, including infections, and publish original clinical medicine research in peer-reviewed journals.
On that account, he received his NIW approval in 18 days only with our team’s efforts and the Premium Processing Service. We are pleased to have been a part of his success story and would like to wish him good luck in his upcoming endeavors.